KinDex Pharmaceuticals Company
.jpg)
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Total Funding:
$5 827 274
Headquarters:
Seattle, Washington, United States
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Last Funding Type:
Debt Financing
Last Funding Date:
2016-08-30
Founded Date:
2009-01-01
Industry:
Longevity